L575-0930 Screening compound: 1-methyl-5-(3-{[2-(2-methylpiperidin-1-yl)ethyl]carbamoyl}propanoyl)-N-phenyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

L575-0930 Screening compound: 1-methyl-5-(3-{[2-(2-methylpiperidin-1-yl)ethyl]carbamoyl}propanoyl)-N-phenyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide
L575-0930 Screening compound: 1-methyl-5-(3-{[2-(2-methylpiperidin-1-yl)ethyl]carbamoyl}propanoyl)-N-phenyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L575-0930
1-methyl-5-(3-{[2-(2-methylpiperidin-1-yl)ethyl]carbamoyl}propanoyl)-N-phenyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L575-0930

Molecular Formula

C26H36N6O3 (C26 H36 N6 O3)

Compound Name

1-methyl-5-(3-{[2-(2-methylpiperidin-1-yl)ethyl]carbamoyl}propanoyl)-N-phenyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carboxamide

IUPAC name

1-methyl-5-(3-{[2-(2-methylpiperidin-1-yl)ethyl]carbamoyl}propanoyl)-N-phenyl-1H4H5H6H7H-pyrazolo[43-c]pyridine-3-carboxamide

SMILES

CC1N(CCNC(CCC(N(CC2)Cc3c2n(C)nc3C(Nc2ccccc2)=O)=O)=O)CCCC1

InChI

InChI=1S/C26H36N6O3/c1-19-8-6-7-15-31(19)17-14-27-23(33)11-12-24(34)32-16-13-22-21(18-32)25(29-30(22)2)26(35)28-20-9-4-3-5-10-20/h3-5,9-10,19H,6-8,11-18H2,1-2H3,(H,27,33)(H,28,35)/t19-/m0/s1

InChI Key

NAEXOLWBAMDJDQ-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27463646

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.398

Distribution Coefficient, logD

-1.575

Water Solubility, LogSw

-2.10

Polar Surface Area

81.876

Acid Dissociation Constant (pKa)

11.40

Base Dissociation Constant (pKb)

9.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

53.80

L575-0930 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

MCL1 Targeted Library (12200 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
Targets:
  • Proteases
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with L575-0930 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L575-0930?
Check Price and Availability of L575-0930, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L575-0930 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L575-0930
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L575-0930
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L575-0930 available by request